LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER
Clinical trials for LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Antibody-Chemo combo shows promise in slowing stomach cancer
Disease control OngoingThis Phase 3 trial tests whether adding zolbetuximab, an antibody that targets the Claudin 18.2 protein found on many stomach tumors, to standard chemotherapy can delay cancer progression in people with advanced stomach or gastroesophageal junction cancer. About 565 adults whose …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug combo shows promise against tough stomach cancer
Disease control OngoingThis study tests whether adding zolbetuximab (a drug that targets a protein called Claudin 18.2 found on many stomach tumors) to standard chemotherapy helps people with advanced stomach or gastroesophageal junction cancer live longer without their cancer growing. About 500 adults…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA OR CANCER
Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC